Skip to main content

Breast Cancer Research and Treatment

Ausgabe 3/2012

Inhalt (45 Artikel)

Review

Docetaxel-containing adjuvant chemotherapy in patients with early stage breast cancer. Consistency of effect independent of nodal and biomarker status: a meta-analysis of 14 randomized clinical trials

Jean-Philippe Jacquin, Stephen Jones, Nicolas Magné, Céline Chapelle, Paul Ellis, Wolfgang Janni, Dimitrios Mavroudis, Miguel Martín, Silvy Laporte

Review

A prospective study of breast lymphedema: frequency, symptoms, and quality of life

Amy C. Degnim, Joyce Miller, Tanya L. Hoskin, Judy C. Boughey, Margie Loprinzi, Kristine Thomsen, Shaun Maloney, Larry M. Baddour, Andrea L. Cheville

Preclinical Study

Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients

Heidi Schwarzenbach, Karin Milde-Langosch, Bettina Steinbach, Volkmar Müller, Klaus Pantel

Open Access Preclinical Study

Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer

Neng Wang, Zhi-Yu Wang, Sui-Lin Mo, Tjing Yung Loo, Dong-Mei Wang, Hai-Bin Luo, De-Po Yang, Yu-Ling Chen, Jian-Gang Shen, Jian-Ping Chen

Preclinical Study

Atypical ezrin localization as a marker of locally advanced breast cancer

Alan A. Arslan, Deborah Silvera, Rezina Arju, Shah Giashuddin, Ilana Belitskaya-Levy, Silvia C. Formenti, Robert J. Schneider

Preclinical Study

Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway

Li-Ching Chen, Shih-Hsin Tu, Ching-Shui Huang, Ching-Shyang Chen, Chi-Tang Ho, Hsiao-Wei Lin, Chia-Hwa Lee, Hui-Wen Chang, Chien-Hsi Chang, Chih-Hsiung Wu, Wen-Sen Lee, Yuan-Soon Ho

Open Access Preclinical study

Germline copy number variants are not associated with globally acquired copy number changes in familial breast tumours

Logan C. Walker, Lutz Krause, Amanda B. Spurdle, Nic Waddell

Preclinical Study

Non-invasive quantification of tumor vascular architecture during docetaxel-chemotherapy

Karine Mahéo, Stephan Chevalier, Sophie Vibet, Philippe Bougnoux, Serge Richard, Sophie Serrière, Aurore Bleuzen, François Tranquart, Caroline Goupille

Preclinical Study

Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation

Matthew J. Sikora, Viktoriya Strumba, Marc E. Lippman, Michael D. Johnson, James M. Rae

Preclinical Study

Targeting of mTORC2 prevents cell migration and promotes apoptosis in breast cancer

Haiyan Li, Jun Lin, Xiaokai Wang, Guangyu Yao, Liping Wang, Hang Zheng, Cuilan Yang, Chunhong Jia, Anling Liu, Xiaochun Bai

Preclinical Study

Notch2 activation by benzyl isothiocyanate impedes its inhibitory effect on breast cancer cell migration

Su-Hyeong Kim, Anuradha Sehrawat, Shivendra V. Singh

Preclinical Study

MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer

Chun-Wen Cheng, Hsiao-Wei Wang, Chia-Wei Chang, Hou-Wei Chu, Cheng-You Chen, Jyh-Cherng Yu, Jui-I Chao, Huei-Fang Liu, Shian-ling Ding, Chen-Yang Shen

Preclinical Study

Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance

Yi-ling Yang, Yu Fan, Rong-gang Lang, Feng Gu, Mei-Jing Ren, Xin-Min Zhang, Dong Yin, Li Fu

Preclinical Study

Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study

Anneke Q. van Hoesel, Cornelis J. H. van de Velde, Peter J. K. Kuppen, Gerrit Jan Liefers, Hein Putter, Yusuke Sato, David A. Elashoff, Roderick R. Turner, Jaime M. Shamonki, Esther M. de Kruijf, Johanna G. H. van Nes, Armando E. Giuliano, Dave S. B. Hoon

Clinical trial

Nomogram for predicting positive resection margins after breast-conserving surgery

Hee-Chul Shin, Wonshik Han, Hyeong-Gon Moon, Nariya Cho, Woo Kyung Moon, In-Ae Park, Sung Jun Park, Dong-Young Noh

Clinical Trial

Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use?

Jeffrey G. Schneider, Danny N. Khalil

Clinical Trial

Estrogen receptor status confers a distinct pattern of response to neoadjuvant chemotherapy: implications for optimal durations of therapy

Hyeong-Gon Moon, Seock-Ah Im, Wonshik Han, Do-Youn Oh, Sae-Won Han, Bhumsuk Keam, In Ae Park, Jung Min Chang, Woo Kyung Moon, Nariya Cho, Dong-Young Noh

Clinical Trial

Lipid profiles within the SABRE trial of anastrozole with and without risedronate

Catherine Van Poznak, Andreas Makris, Glen Clack, David H. Barlow, Richard Eastell

Open Access Clinical trial

A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer

Martin Schuler, Ahmad Awada, Philipp Harter, Jean Luc Canon, Kurt Possinger, Marcus Schmidt, Jacques De Grève, Patrick Neven, Luc Dirix, Walter Jonat, Matthias W. Beckmann, Jochen Schütte, Peter A. Fasching, Nina Gottschalk, Tatiana Besse-Hammer, Frank Fleischer, Sven Wind, Martina Uttenreuther-Fischer, Martine Piccart, Nadia Harbeck

Clinical Trial

Efficacy and safety of concurrent trastuzumab plus weekly paclitaxel–FEC as primary therapy for HER2-positive breast cancer in everyday clinical practice

Sonia Pernas, Miguel Gil-Gil, María Ochoa de Olza, Anna Gumà, Fina Climent, Anna Petit, María Jesús Pla, Amparo García-Tejedor, Ana López-Ojeda, Cati Falo, Adela Fernandez-Otega, Carlos Mesia, Francisco Javier Pérez-Martin, Ander Urruticoechea, Josep Ramon Germà

Clinical trial

The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study

Luca G. Campana, Sara Valpione, Cristina Falci, Simone Mocellin, Michela Basso, Luigi Corti, Nicola Balestrieri, Alberto Marchet, Carlo R. Rossi

Clinical Trial

Impact of real-time virtual sonography, a coordinated sonography and MRI system that uses an image fusion technique, on the sonographic evaluation of MRI-detected lesions of the breast in second-look sonography

Shogo Nakano, Junko Kousaka, Kimihito Fujii, Kyoko Yorozuya, Miwa Yoshida, Yukako Mouri, Miwa Akizuki, Rie Tetsuka, Takahito Ando, Takashi Fukutomi, Yukihiko Oshima, Junko Kimura, Tsuneo Ishiguchi, Osamu Arai

Epidemiology

Accuracy of BRCA1/2 mutation prediction models in Korean breast cancer patients

Eunyoung Kang, Sue K. Park, Jae Jeong Yang, Boyoung Park, Min Hyuk Lee, Jong Won Lee, Young Jin Suh, Jeong Eon Lee, Hyun-Ah Kim, Se Jeong Oh, Sung-Won Kim

Epidemiology

Disparities in breast cancer mortality trends in a middle income country

Ana Maria Pedraza, Marina Pollán, Roberto Pastor-Barriuso, Anna Cabanes

Epidemiology

Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry

Meghan E. Work, Irene L. Andrulis, Esther M. John, John L. Hopper, Yuyan Liao, Fang Fang Zhang, Julia A. Knight, Dee W. West, Roger L. Milne, Graham G. Giles, Teri A. Longacre, Frances O’Malley, Anna Marie Mulligan, Melissa C. Southey, Hanina Hibshoosh, Mary Beth Terry

Epidemiology

Mastectomy without radiotherapy: outcome analysis after 10 years of follow-up in a single institution

E. Botteri, O. Gentilini, N. Rotmensz, P. Veronesi, S. Ratini, C. Fraga-Guedes, A. Toesca, C. Sangalli, A. Del Castillo, M. Rietjens, G. Viale, R. Orecchia, A. Goldhirsch, U. Veronesi

Epidemiology

Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management

Simone Heidemann, Christine Fischer, Christoph Engel, Barbara Fischer, Lana Harder, Brigitte Schlegelberger, Dieter Niederacher, Timm O. Goecke, Sandra C. Doelken, Nicola Dikow, Walter Jonat, Susanne Morlot, Rita C. Schmutzler, Norbert K. Arnold

Epidemiology

Tumour characteristics among women with very low-risk breast cancer

S. A. Narod, A. Valentini, S. Nofech-Mozes, P. Sun, W. Hanna

Epidemiology

Cardiometabolic factors and breast cancer risk in U.S. black women

Jaclyn L. F. Bosco, Julie R. Palmer, Deborah A. Boggs, Elizabeth E. Hatch, Lynn Rosenberg

Epidemiology

Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990–2008

Jennifer A. Schlichting, Amr S. Soliman, Catherine Schairer, David Schottenfeld, Sofia D. Merajver

Epidemiology

Selenium intake and breast cancer mortality in a cohort of Swedish women

Holly R. Harris, Leif Bergkvist, Alicja Wolk

Epidemiology

Accelerometer-based measures of active and sedentary behavior in relation to breast cancer risk

Cher M. Dallal, Louise A. Brinton, Charles E. Matthews, Jolanta Lissowska, Beata Peplonska, Terryl J. Hartman, Gretchen L. Gierach

Epidemiology

Patterns of bone density evaluation in a community population treated with aromatase inhibitors

Jennifer A. Ligibel, A. James O’Malley, Maxine Fisher, Gregory W. Daniel, Eric P. Winer, Nancy L. Keating

Epidemiology

Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer

Haeyoung Kim, Dae-Yeon Cho, Doo Ho Choi, Su-Youn Choi, Inkyung Shin, Won Park, Seung Jae Huh, Sung-Hee Han, Min Hyuk Lee, Sei Hyun Ahn, Byung Ho Son, Sung-Won Kim, Bruce G. Haffty

Epidemiology

The impact of an electronic health questionnaire on symptom management and behavior reporting for breast cancer survivors

Meredith Bock, Dan Moore, Jimmy Hwang, Dianne Shumay, Laurell Lawson, Deborah Hamolsky, Laura Esserman, Hope Rugo, A. Jo Chien, John Park, Pamela Munster, Michelle Melisko

Brief Report

Mutational analysis of telomere genes in BRCA1/2-negative breast cancer families with very short telomeres

Kira Yanowsky, Alicia Barroso, Ana Osorio, Miguel Urioste, Javier Benitez, Beatriz Martinez-Delgado

Letter to the Editor

Letter in response: the value of mammography screening

Robert C. Burton, Robin J. Bell

Letter to the Editor

Comments on adolescent intakes of vitamin D and calcium and incidence of proliferative benign breast disease

Chun Zhang, Guo-Qiang Lv, Jian-Ping Li, Ping Zhou

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.